SEC Form 4 · accession 0001209191-15-083072
AYTU BIOPHARMA, INC · AYTU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ampio Pharmaceuticals, Inc.
10% Owner
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 10:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2015 | J | 10,399,661 | $0.00 | D | 1,226,407 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is a distribution by Ampio Pharmaceuticals, Inc. of the Issuer's shares to the shareholders of Ampio Pharmaceuticals, Inc.